ACCC Statement on Administration's MA & Part D Proposal to Tackle Drug Prices

On Friday, December 14, the Association of Community Cancer Centers (ACCC) issued a policy statement expressing deep concern regarding the broad impact of the Trump Administration's proposed changes to Medicare Advantage and Part D on the nation's cancer care delivery infrastructure and, in particular, on those cancer programs and practices that see a high percentage of Medicare, Medicare only, and dual eligible patients. 

The Centers for Medicare & Medicaid Services (CMS) announced the potential changes in a proposed rule that was released on November 26.

Read ACCC's Policy Statement.

Posted 12/17/2018